At Aker BioMarine, our mission is to help combat lifestyle diseases due to the unique combination of nutrients in krill oil. In 2016, about one billion daily doses of Superba Krill were sold worldwide, supporting the health of millions of people.
Through our development of marine ingredients for nutraceutical, aquaculture and fish feed applications we supply the market with phospholipid-bound omega-3s EPA and DHA that have been shown through clinical study to impact health in many ways.
Non-communicable diseases (NCDs), also known as chronic diseases not passed from person to person, are caused by aging, rapid unplanned urbanization and the globalization of unhealthy lifestyles. Every year, 38 million lives are lost to NCDs, of which 16 million or 42% were premature and avoidable. Tobacco use, physical inactivity, unhealthy diet and alcohol abuse are factors that increase the risk of NCDs and are behavioral risk factors that an individual can reduce if informed and motivated. This is why, when we talk about health, we do not promote omega-3s in isolation, but as part of a healthy lifestyle.
A 2016 study conducted by Food Supplements Europe demonstrated that for every dollar a consumer spends on omega-3 products, savings of $2.3 is generated across the healthcare system. Based on this estimate, Aker BioMarine potentially reduced society’s healthcare costs by more than $9 billion in 2016.
Vigilant respect for the ecosystem in which we fish for krill ensures that we can continue to improve human health globally with minimal adverse environmental impact. Our all-hands-on-deck approach to sustainability is, first and foremost, sound business.